These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 33181391)

  • 1. Levodopa responsive-generalized dystonic spells and moaning in DNAJC6 related Juvenile Parkinson's disease.
    Mittal SO
    Parkinsonism Relat Disord; 2020 Dec; 81():188-189. PubMed ID: 33181391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAJC6 mutation causing cranial-onset dystonia with tremor dominant levodopa non-responsive parkinsonism: A novel phenotype.
    Ray S; Padmanabha H; Mahale R; Mailankody P; Arunachal G
    Parkinsonism Relat Disord; 2021 Aug; 89():1-3. PubMed ID: 34175496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia.
    Ng J; Cortès-Saladelafont E; Abela L; Termsarasab P; Mankad K; Sudhakar S; Gorman KM; Heales SJR; Pope S; Biassoni L; Csányi B; Cain J; Rakshi K; Coutts H; Jayawant S; Jefferson R; Hughes D; García-Cazorla À; Grozeva D; Raymond FL; Pérez-Dueñas B; De Goede C; Pearson TS; Meyer E; Kurian MA
    Mov Disord; 2020 Aug; 35(8):1357-1368. PubMed ID: 32472658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease.
    Olgiati S; Quadri M; Fang M; Rood JP; Saute JA; Chien HF; Bouwkamp CG; Graafland J; Minneboo M; Breedveld GJ; Zhang J; ; Verheijen FW; Boon AJ; Kievit AJ; Jardim LB; Mandemakers W; Barbosa ER; Rieder CR; Leenders KL; Wang J; Bonifati V
    Ann Neurol; 2016 Feb; 79(2):244-56. PubMed ID: 26528954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability.
    Köroğlu Ç; Baysal L; Cetinkaya M; Karasoy H; Tolun A
    Parkinsonism Relat Disord; 2013 Mar; 19(3):320-4. PubMed ID: 23211418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype Analysis on the Relationship of the DNAJC6 Gene with Early-Onset Parkinson's Disease Risk in a Chinese Population.
    Shen T; Zhao S; Jiang Y; Pu J; Lai HY; Yan Y; Tian J; Chen Y; Zhang B
    J Parkinsons Dis; 2019; 9(1):109-120. PubMed ID: 30373961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.
    Sage JI; McHale DM; Sonsalla P; Vitagliano D; Heikkila RE
    Neurology; 1989 Jul; 39(7):888-91. PubMed ID: 2472582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.
    Shi C; Li F; Yang J; Zhang S; Mao C; Wang H; Shi M; Liu Y; Song B; Xu Y
    Neurosci Lett; 2016 Nov; 634():60-62. PubMed ID: 27687717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?
    Lamberti P; de Mari M; Iliceto G; Federico F
    Acta Neurol (Napoli); 1992; 14(4-6):451-4. PubMed ID: 1293988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystonia in Parkinson's disease: clinical and pharmacological features.
    Poewe WH; Lees AJ; Stern GM
    Ann Neurol; 1988 Jan; 23(1):73-8. PubMed ID: 3345068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features].
    Miwa H; Mizuno Y
    No To Shinkei; 1996 Feb; 48(2):149-54. PubMed ID: 8865694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease.
    Ho B; Prakash R; Morgan JC; Sethi KD
    Nat Clin Pract Neurol; 2007 Sep; 3(9):526-30. PubMed ID: 17805247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Dopa-responsive dystonia and Parkinson's disease related disorders? A case report.
    Eggers C; Volk AE; Kahraman D; Fink GR; Leube B; Schmidt M; Timmermann L
    Parkinsonism Relat Disord; 2012 Jun; 18(5):666-8. PubMed ID: 22030322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dystonia in Parkinson's disease.
    Tsui JK
    Adv Neurol; 2003; 91():361-4. PubMed ID: 12442694
    [No Abstract]   [Full Text] [Related]  

  • 15. A tale of two patients: Levodopa and creative awakening in parkinson's disease - A qualitative report.
    Chacko J; George S; Cyriac S; Chakrapani B
    Asian J Psychiatr; 2019 Jun; 43():179-181. PubMed ID: 31212166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Parkinson's disease following dystonia].
    Yasuda C; Takei T; Uozumi T; Toyota T; Yuhi T; Adachi H
    Rinsho Shinkeigaku; 2016 Sep; 56(9):600-4. PubMed ID: 27498816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
    Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
    Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of c.801-2A>G mutation in the DNAJC6 gene in Parkinson's disease in southern Spain.
    Jesús S; Gómez-Garre P; Carrillo F; Cáceres-Redondo MT; Huertas-Fernández I; Bernal-Bernal I; Bonilla-Toribio M; Vargas-González L; Carballo M; Mir P
    Parkinsonism Relat Disord; 2014 Feb; 20(2):248-9. PubMed ID: 24220513
    [No Abstract]   [Full Text] [Related]  

  • 19. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
    Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystonia in Parkinson's disease.
    Tolosa E; Compta Y
    J Neurol; 2006 Dec; 253 Suppl 7():VII7-13. PubMed ID: 17131231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.